Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Medication Abortion Via Pharmacy Dispensing

ClinicalTrials.gov ID: NCT03320057

Public ClinicalTrials.gov record NCT03320057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Alternative Provision of Medication Abortion Via Pharmacy Dispensing

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This mixed-methods study follows a prospective cohort of patients receiving Mifeprex ® (mifepristone) for medication abortion dispensed by pharmacists after undergoing standard clinical evaluation. Women participating in this study will obtain mifepristone and misoprostol from the pharmacy instead of in the clinic. To assess feasibility, acceptability, and effectiveness of pharmacy dispensing of mifepristone, the study will survey patients, evaluate their clinical outcomes from electronic health records, and survey and interview pharmacists at study sites.

Study identification

NCT ID
NCT03320057
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Daniel Grossman
Other
Enrollment
326 participants

Conditions and interventions

Eligibility (public fields only)

Age range
15 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2018
Primary completion
Jul 3, 2020
Completion
Jul 3, 2020
Last update posted
Jul 11, 2021

2018 – 2020

United States locations

U.S. sites
6
U.S. states
2
U.S. cities
5
Facility City State ZIP Site status
Obstetrics and Gynecology Family Planning Clinic at University of California Davis Sacramento California 95817
Women's Health Services at University of California San Diego San Diego California 92103
Kaiser Permanente Northern California San Francisco California 94115
Mt. Zion Women's Options Clinic, University San Francisco California 94115
University of Washington Seattle Washington 98105
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03320057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2021 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03320057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →